Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : SARS - what next? -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (367)	5/2/2003 2:31:17 PM
From: RealMuLan	Respond to of 1070

Colby, about your rheumatoid arthritis, maybe you should try MSM. I know a person, and read from many people, take it, high dose, 4gram in the morning and 4 gram in the evening, and 3 months or so, the pain reduced significantly, and 6 months later, the pain has gone. I take it too, just for fun<g>, and noticed that my figure nail grows really fast, and my allergy is completely gone. Do a search on the net, you can find a lot of information about it and comment from users. Disclaimer: no any medical advise intended.

To: Ilaine who wrote (367)	1/15/2004 6:11:32 AM
From: Maurice Winn	Read Replies (1) \| Respond to of 1070

Genetic vulnerability to sars: canada.com <Thursday, January 15, 2004 HONG KONG (AP) - A new study has found people with a particular gene are much more susceptible to SARS, scientists said Thursday. Researchers from the Chinese University of Hong Kong said they discovered people who have one specific genetic marker known as HLA-Bml>0703 have a far higher risk of contracting severe acute respiratory syndrome. But those with another genetic marker, HLA-DRB1ml>0301, have more resistance against the respiratory disease, researchers said. HLA, or human leucocyte antigen, genes can produce proteins that appear on the surface of white blood cells. "These two markers are very important in predicting the outcome of people who are in contact with this virus," said Dr. Joseph Sung, director of the university's Centre for Emerging Infectious Diseases. The study could help identify people who are at higher risk of catching the disease and would allow doctors to give more aggressive treatment to patients who are more likely to become severely ill, Sung said. The study examined the blood samples of 90 SARS patients between the ages of 22 and 85 who were in hospital in Hong Kong between March and June last year. It compared the patients with Hong Kong's general population through samples obtained from 18,774 healthy bone-marrow donors. Sung said the findings are preliminary and researchers are planning a larger-scale study, which could include tests on the families of SARS patients to see why some members become ill while others do not. "The test still needs a lot of refinement and we need to look into the mechanism of why these markers are indicating a person's susceptibility," he said. The research findings will be published in the Journal of Infectious Diseases, the researchers said. ... > Mqurice